Hunan Academy of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, 410013, China.
The First Hospital of Hunan University of Chinese Medicine, Central Laboratory, Changsha, Hunan, 410007, China.
J Ethnopharmacol. 2020 Nov 15;262:113160. doi: 10.1016/j.jep.2020.113160. Epub 2020 Jul 28.
Siwu Paste (SWP) was recorded in the first national Pharmacopoeia of China, "Tai Ping Hui Min He Ji Ju Fang", it showed excellent effects in regulating all syndromes relevant to blood.
This study aimed to investigate the protective effects of Siwu Paste (SWP) on bone marrow hematopoietic by using rats' model with blood deficiency syndrome induced by chemotherapy.
Animal model with blood deficiency syndrome was successfully established by evaluating their peripheral blood cell level and erythrocyte membrane energy metabolism enzyme activity. Serum hematopoietic cytokine levels were detected by using Enzyme-linked immunosorbent assay (ELISA). Hematoxylin-Eosin (HE) staining method was used to observe the pathological morphology of femur bone marrow, and the viability of BMSC was detected by Cell Counting Kit (CCK-8). Furthermore, the expression of toll-like receptor 4 (TLR4), nuclear transcription factor kB (NF-κB), and NOD-like receptor protein 3 (NLRP3) protein in femur bone marrow were detected by using Western-blotting and High-content cell imaging analysis system (HCA).
Obtained results showed that SWP could significantly improve the status of anemia, regulate the expressions of serum hematopoietic cytokines, and protect bone marrow hematopoietic cells. Furthermore, the expressions of TLR4, NF-κB, and NLRP3 protein were inhibited in bone marrow hematopoietic cells.
Siwu Paste (SWP) could recover the bone marrow hematopoietic functions in rats with blood deficiency syndrome. The therapeutic mechanism may be related to the regulation of serum hematopoietic cytokines, and inhibition of TLR4/NF-κB/NLRP3 signaling pathway.
四物汤(SWP)最早记录于中国第一部国家药典《太平惠民和剂局方》中,在调节与血液相关的所有证候方面表现出了极佳的效果。
本研究旨在通过建立化疗致血虚证大鼠模型,探讨四物汤(SWP)对骨髓造血的保护作用。
通过评估外周血血细胞水平和红细胞膜能量代谢酶活性,成功建立血虚证动物模型。采用酶联免疫吸附试验(ELISA)检测血清造血细胞因子水平。采用苏木精-伊红(HE)染色法观察股骨骨髓病理形态,采用细胞计数试剂盒(CCK-8)检测骨髓间充质干细胞(BMSC)活力。进一步采用Western-blotting 和高内涵细胞成像分析系统(HCA)检测股骨骨髓中 Toll 样受体 4(TLR4)、核转录因子 kB(NF-κB)和 NOD 样受体蛋白 3(NLRP3)蛋白的表达。
结果表明,SWP 可显著改善贫血状态,调节血清造血细胞因子表达,保护骨髓造血细胞。此外,SWP 还可抑制骨髓造血细胞中 TLR4、NF-κB 和 NLRP3 蛋白的表达。
四物汤(SWP)可恢复血虚证大鼠的骨髓造血功能。其治疗机制可能与调节血清造血细胞因子以及抑制 TLR4/NF-κB/NLRP3 信号通路有关。